In a Dutch nationwide register-based study, older men with intermediate- or high-risk prostate cancer less often received treatment with curative intent also after consideration of tumor characteristics, PSA-levels, and comorbidity burden [2]. This evidence concerns the gene KLK3 and neoplasm.